To determine the difference in time to recovery and healing of monkey pox lesions between people receiving Tecovirimat and those receiving placebo. People with severe cases of monkeypox will receive Tecovirimat and not placebo.
Thomas Patterson
(210) 567-4666
patterson@uthscsa.edu
Robin Tragus
(210) 567-5262
tragus@uthscsa.edu
Principal Investigator
Thomas Patterson
Thomas Patterson
(210) 567-4666
patterson@uthscsa.edu
Irma Scholler
+1 (210) 450-3150
scholler@uthscsa.edu
Robin Tragus
(210) 567-5262
tragus@uthscsa.edu
Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion
Illness < 14 days before study entry, have at least 1 active (not scabbed) lesion